aluates Reports

$ 0.0

Automative

Global Combined Polio Vaccine Market Research Report 2024

Published Date: December 2024

Report Code: QYRE-Auto-12Q18734

BUY CHAPTERS

Global Combined Polio Vaccine Market Research Report 2024

Code: QYRE-Auto-12Q18734

Report

December 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Mitsubishi Chemical Group Corp

Meiji Holdings Co. Ltd.

Combined Polio Vaccine Market Size

The global market for Combined Polio Vaccine was valued at US$ 284 million in the year 2023 and is projected to reach a revised size of US$ 404 million by 2030, growing at a CAGR of 5.2% during the forecast period.

Combined Polio Vaccine Market

Combined polio vaccine (IPV) is a formulation with multiple vaccine components that protects against poliomyelitis (polio) as well as specific diseases such as pertussis, diphtheria and tetanus. This combined vaccine can activate the immune response to multiple pathogens at the same time, reduce the number of vaccinations, improve the efficiency of vaccination, and provide comprehensive protection for children.

North American market for Combined Polio Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Combined Polio Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Combined Polio Vaccine include Mitsubishi Chemical Group Corp., Meiji Holdings Co., Ltd., Panacea Biotec Ltd., Boryung Corp., Merck & Co., Inc., Sanofi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Combined Polio Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combined Polio Vaccine.

The Combined Polio Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Combined Polio Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Combined Polio Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Combined Polio Vaccine Market Report

Report Metric	Details
Report Name	Combined Polio Vaccine Market
Accounted market size in year	US$ 284 million
Forecasted market size in 2030	US$ 404 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2030
by Type	1 Dose 3 Doses 4 Doses
by Application	Hospital Clinic Others
Production by Region	North America Europe Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Mitsubishi Chemical Group Corp., Meiji Holdings Co., Ltd., Panacea Biotec Ltd., Boryung Corp., Merck & Co., Inc., Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Combined Polio Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Combined Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Combined Polio Vaccine Market growing?

Ans: The Combined Polio Vaccine Market witnessing a CAGR of 5.2% during the forecast period 2025-2030.

What is the Combined Polio Vaccine Market size in 2030?

Ans: The Combined Polio Vaccine Market size in 2030 will be US$ 404 million.

Who are the main players in the Combined Polio Vaccine Market report?

Ans: The main players in the Combined Polio Vaccine Market are Mitsubishi Chemical Group Corp., Meiji Holdings Co., Ltd., Panacea Biotec Ltd., Boryung Corp., Merck & Co., Inc., Sanofi

What are the Application segmentation covered in the Combined Polio Vaccine Market report?

Ans: The Applications covered in the Combined Polio Vaccine Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Combined Polio Vaccine Market report?

Ans: The Types covered in the Combined Polio Vaccine Market report are 1 Dose, 3 Doses, 4 Doses

1 Combined Polio Vaccine Market Overview

1.1 Product Definition

1.2 Combined Polio Vaccine by Type

1.2.1 Global Combined Polio Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 1 Dose

1.2.3 3 Doses

1.2.4 4 Doses

1.3 Combined Polio Vaccine by Application

1.3.1 Global Combined Polio Vaccine Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Combined Polio Vaccine Market Size Estimates and Forecasts

1.4.1 Global Combined Polio Vaccine Revenue 2019-2030

1.4.2 Global Combined Polio Vaccine Sales 2019-2030

1.4.3 Global Combined Polio Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Combined Polio Vaccine Market Competition by Manufacturers

2.1 Global Combined Polio Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Combined Polio Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Combined Polio Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Combined Polio Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Combined Polio Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Combined Polio Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Combined Polio Vaccine, Date of Enter into This Industry

2.8 Global Combined Polio Vaccine Market Competitive Situation and Trends

2.8.1 Global Combined Polio Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Combined Polio Vaccine Players Market Share by Revenue

2.8.3 Global Combined Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Combined Polio Vaccine Market Scenario by Region

3.1 Global Combined Polio Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Combined Polio Vaccine Sales by Region: 2019-2030

3.2.1 Global Combined Polio Vaccine Sales by Region: 2019-2024

3.2.2 Global Combined Polio Vaccine Sales by Region: 2025-2030

3.3 Global Combined Polio Vaccine Revenue by Region: 2019-2030

3.3.1 Global Combined Polio Vaccine Revenue by Region: 2019-2024

3.3.2 Global Combined Polio Vaccine Revenue by Region: 2025-2030

3.4 North America Combined Polio Vaccine Market Facts & Figures by Country

3.4.1 North America Combined Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Combined Polio Vaccine Sales by Country (2019-2030)

3.4.3 North America Combined Polio Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Combined Polio Vaccine Market Facts & Figures by Country

3.5.1 Europe Combined Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Combined Polio Vaccine Sales by Country (2019-2030)

3.5.3 Europe Combined Polio Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Combined Polio Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Combined Polio Vaccine Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Combined Polio Vaccine Sales by Region (2019-2030)

3.6.3 Asia Pacific Combined Polio Vaccine Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Combined Polio Vaccine Market Facts & Figures by Country

3.7.1 Latin America Combined Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Combined Polio Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Combined Polio Vaccine Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Combined Polio Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Combined Polio Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Combined Polio Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Combined Polio Vaccine Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Combined Polio Vaccine Sales by Type (2019-2030)

4.1.1 Global Combined Polio Vaccine Sales by Type (2019-2024)

4.1.2 Global Combined Polio Vaccine Sales by Type (2025-2030)

4.1.3 Global Combined Polio Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Combined Polio Vaccine Revenue by Type (2019-2030)

4.2.1 Global Combined Polio Vaccine Revenue by Type (2019-2024)

4.2.2 Global Combined Polio Vaccine Revenue by Type (2025-2030)

4.2.3 Global Combined Polio Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Combined Polio Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Combined Polio Vaccine Sales by Application (2019-2030)

5.1.1 Global Combined Polio Vaccine Sales by Application (2019-2024)

5.1.2 Global Combined Polio Vaccine Sales by Application (2025-2030)

5.1.3 Global Combined Polio Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Combined Polio Vaccine Revenue by Application (2019-2030)

5.2.1 Global Combined Polio Vaccine Revenue by Application (2019-2024)

5.2.2 Global Combined Polio Vaccine Revenue by Application (2025-2030)

5.2.3 Global Combined Polio Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Combined Polio Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Mitsubishi Chemical Group Corp.

6.1.1 Mitsubishi Chemical Group Corp. Company Information

6.1.2 Mitsubishi Chemical Group Corp. Description and Business Overview

6.1.3 Mitsubishi Chemical Group Corp. Combined Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Mitsubishi Chemical Group Corp. Combined Polio Vaccine Product Portfolio

6.1.5 Mitsubishi Chemical Group Corp. Recent Developments/Updates

6.2 Meiji Holdings Co., Ltd.

6.2.1 Meiji Holdings Co., Ltd. Company Information

6.2.2 Meiji Holdings Co., Ltd. Description and Business Overview

6.2.3 Meiji Holdings Co., Ltd. Combined Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Meiji Holdings Co., Ltd. Combined Polio Vaccine Product Portfolio

6.2.5 Meiji Holdings Co., Ltd. Recent Developments/Updates

6.3 Panacea Biotec Ltd.

6.3.1 Panacea Biotec Ltd. Company Information

6.3.2 Panacea Biotec Ltd. Description and Business Overview

6.3.3 Panacea Biotec Ltd. Combined Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Panacea Biotec Ltd. Combined Polio Vaccine Product Portfolio

6.3.5 Panacea Biotec Ltd. Recent Developments/Updates

6.4 Boryung Corp.

6.4.1 Boryung Corp. Company Information

6.4.2 Boryung Corp. Description and Business Overview

6.4.3 Boryung Corp. Combined Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boryung Corp. Combined Polio Vaccine Product Portfolio

6.4.5 Boryung Corp. Recent Developments/Updates

6.5 Merck & Co., Inc.

6.5.1 Merck & Co., Inc. Company Information

6.5.2 Merck & Co., Inc. Description and Business Overview

6.5.3 Merck & Co., Inc. Combined Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Merck & Co., Inc. Combined Polio Vaccine Product Portfolio

6.5.5 Merck & Co., Inc. Recent Developments/Updates

6.6 Sanofi

6.6.1 Sanofi Company Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Combined Polio Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sanofi Combined Polio Vaccine Product Portfolio

6.6.5 Sanofi Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Combined Polio Vaccine Industry Chain Analysis

7.2 Combined Polio Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Combined Polio Vaccine Production Mode & Process

7.4 Combined Polio Vaccine Sales and Marketing

7.4.1 Combined Polio Vaccine Sales Channels

7.4.2 Combined Polio Vaccine Distributors

7.5 Combined Polio Vaccine Customers

8 Combined Polio Vaccine Market Dynamics

8.1 Combined Polio Vaccine Industry Trends

8.2 Combined Polio Vaccine Market Drivers

8.3 Combined Polio Vaccine Market Challenges

8.4 Combined Polio Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Mitsubishi Chemical Group Corp

Meiji Holdings Co. Ltd.

List of Tables

Table 1. Global Combined Polio Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Combined Polio Vaccine Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Combined Polio Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Combined Polio Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Combined Polio Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Combined Polio Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Combined Polio Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Combined Polio Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Combined Polio Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Combined Polio Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Combined Polio Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Combined Polio Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Combined Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combined Polio Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Combined Polio Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Combined Polio Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Combined Polio Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Combined Polio Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Combined Polio Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Combined Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Combined Polio Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Combined Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Combined Polio Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Combined Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Combined Polio Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Combined Polio Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Combined Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Combined Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Combined Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Combined Polio Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Combined Polio Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Combined Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Combined Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Combined Polio Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Combined Polio Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Combined Polio Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Combined Polio Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Combined Polio Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Combined Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Combined Polio Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Combined Polio Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Combined Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Combined Polio Vaccine Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Combined Polio Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Combined Polio Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Combined Polio Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Combined Polio Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Combined Polio Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Combined Polio Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Combined Polio Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Combined Polio Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Combined Polio Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Combined Polio Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Combined Polio Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Combined Polio Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Combined Polio Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Combined Polio Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Combined Polio Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Combined Polio Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Combined Polio Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Combined Polio Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Combined Polio Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Combined Polio Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Combined Polio Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Combined Polio Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Combined Polio Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Combined Polio Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Combined Polio Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Mitsubishi Chemical Group Corp. Company Information

Table 71. Mitsubishi Chemical Group Corp. Description and Business Overview

Table 72. Mitsubishi Chemical Group Corp. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Mitsubishi Chemical Group Corp. Combined Polio Vaccine Product

Table 74. Mitsubishi Chemical Group Corp. Recent Developments/Updates

Table 75. Meiji Holdings Co., Ltd. Company Information

Table 76. Meiji Holdings Co., Ltd. Description and Business Overview

Table 77. Meiji Holdings Co., Ltd. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Meiji Holdings Co., Ltd. Combined Polio Vaccine Product

Table 79. Meiji Holdings Co., Ltd. Recent Developments/Updates

Table 80. Panacea Biotec Ltd. Company Information

Table 81. Panacea Biotec Ltd. Description and Business Overview

Table 82. Panacea Biotec Ltd. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Panacea Biotec Ltd. Combined Polio Vaccine Product

Table 84. Panacea Biotec Ltd. Recent Developments/Updates

Table 85. Boryung Corp. Company Information

Table 86. Boryung Corp. Description and Business Overview

Table 87. Boryung Corp. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Boryung Corp. Combined Polio Vaccine Product

Table 89. Boryung Corp. Recent Developments/Updates

Table 90. Merck & Co., Inc. Company Information

Table 91. Merck & Co., Inc. Description and Business Overview

Table 92. Merck & Co., Inc. Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Merck & Co., Inc. Combined Polio Vaccine Product

Table 94. Merck & Co., Inc. Recent Developments/Updates

Table 95. Sanofi Company Information

Table 96. Sanofi Description and Business Overview

Table 97. Sanofi Combined Polio Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Sanofi Combined Polio Vaccine Product

Table 99. Sanofi Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Combined Polio Vaccine Distributors List

Table 103. Combined Polio Vaccine Customers List

Table 104. Combined Polio Vaccine Market Trends

Table 105. Combined Polio Vaccine Market Drivers

Table 106. Combined Polio Vaccine Market Challenges

Table 107. Combined Polio Vaccine Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Combined Polio Vaccine

Figure 2. Global Combined Polio Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Combined Polio Vaccine Market Share by Type: 2023 & 2030

Figure 4. 1 Dose Product Picture

Figure 5. 3 Doses Product Picture

Figure 6. 4 Doses Product Picture

Figure 7. Global Combined Polio Vaccine Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Combined Polio Vaccine Market Share by Application: 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Combined Polio Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Combined Polio Vaccine Market Size (2019-2030) & (US$ Million)

Figure 14. Global Combined Polio Vaccine Sales (2019-2030) & (K Units)

Figure 15. Global Combined Polio Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 16. Combined Polio Vaccine Report Years Considered

Figure 17. Combined Polio Vaccine Sales Share by Manufacturers in 2023

Figure 18. Global Combined Polio Vaccine Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Combined Polio Vaccine Players: Market Share by Revenue in Combined Polio Vaccine in 2023

Figure 20. Combined Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Combined Polio Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Combined Polio Vaccine Sales Market Share by Country (2019-2030)

Figure 23. North America Combined Polio Vaccine Revenue Market Share by Country (2019-2030)

Figure 24. United States Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Combined Polio Vaccine Sales Market Share by Country (2019-2030)

Figure 27. Europe Combined Polio Vaccine Revenue Market Share by Country (2019-2030)

Figure 28. Germany Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Combined Polio Vaccine Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Combined Polio Vaccine Revenue Market Share by Region (2019-2030)

Figure 35. China Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Combined Polio Vaccine Sales Market Share by Country (2019-2030)

Figure 43. Mexico Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Combined Polio Vaccine Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Combined Polio Vaccine Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Combined Polio Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Combined Polio Vaccine by Type (2019-2030)

Figure 53. Global Revenue Market Share of Combined Polio Vaccine by Type (2019-2030)

Figure 54. Global Combined Polio Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Combined Polio Vaccine by Application (2019-2030)

Figure 56. Global Revenue Market Share of Combined Polio Vaccine by Application (2019-2030)

Figure 57. Global Combined Polio Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 58. Combined Polio Vaccine Value Chain

Figure 59. Combined Polio Vaccine Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions